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The aim of this research is to evaluate whether posttraining systemic epinephrine is able to improve object recognition memory in
rats with memory deficits produced by traumatic brain injury. Forty-nine two-month-old na¨ıve maleWistar rats were submitted to
surgical procedures to induce traumatic brain injury (TBI) or were sham-operated. Rats were trained in an object recognition task
and, immediately after training, received an intraperitoneal injection of distilledwater (Sham-Veh andTBI-Veh group) or 0.01mg/kg
epinephrine (TBI-Epi group) or no injection (TBI-0 and Sham-0 groups). Retention was tested 3 h and 24 h after acquisition. The
results showed that brain injury produced severe memory deficits and that posttraining administration of epinephrine was able to
reverse them. Systemic administration of distilled water also had an enhancing effect, but of a lower magnitude.These data indicate
that posttraining epinephrine and, to a lesser extent, vehicle injection reducememory deficits associatedwith TBI, probably through
induction of a low-to-moderate emotional arousal.
1. Introduction
Traumatic brain injury (TBI) is a leading cause of chronic
disability in industrialized countries that causes structural
damage and functional deficits due to both primary and
secondary injury mechanisms [1]. The most common dis-
abilities include sensory and motor deficits, along with cog-
nitive problems, including the spheres of attention, episodic
memory, executive functions, working memory, information
processing speed, language functions, and visuospatial pro-
cessing. Among the cognitive deficits, long-term persistence
of memory impairment is quite common [2, 3].
Although many treatments have been tested to reverse
TBI-induced cognitive deficits, it is still necessary to search
for additional therapeutic treatments aimed at reducing
cognitive impairment. Many treatments focus on reducing
neuronal death by administering neuroprotective agents
shortly after trauma [4]. Other treatments are chronically
administered to enhance activation of those functional sys-
tems affected by TBI [5–8]. It is possible that, along with
these treatments, acute treatments administered contingent
to a given task could improve learning and memory in
a phasic way by affecting the specific cognitive processes
triggered by the task, thus extending the treatment strategies
for TBI-inducedmemory deficits. In this sense, enhancement
of memory modulating hormones during or shortly after
training in a learning task could contribute to cognitive
recovery. Posttraining epinephrine is a well-known treatment
able to improve memory consolidation of a variety of tasks
in healthy animals ([9–12]; for review see [13]), and there are
evidences that this effect is higher when memory demands
are increased [11] and with healthy animals endowed with
lower learning capacities [14, 15]. These evidences support
the possibility that posttraining epinephrine could also be
effective in reducing memory deficits in animals with brain
damage.
Taking into account these considerations, the aim of the
current study was to investigate whether the administration
of posttraining epinephrine could reverse object recognition
memory deficits associated with TBI. Previously, it has been
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shown that epinephrine is capable of improving memory for
this task in healthy animals [11]. In order to examine whether
this hormone can also reduce memory deficits after TBI, in
the present work the level of difficulty of the task was adjusted
to ensure that sham-operated rats had a good recall of the
objects, whereas memory deficit was found in TBI animals.
In the present experiment, among the different animal
models developed to reproduce the spectrum of pathological
changes of human TBI, a controlled cortical impact (CCI)
was used. CCI has been widely used in animal research [16]
and produces similar deficits of human TBI, such as learning
and memory deficits [16, 17], including deficits in object
recognition task [18, 19].
2. Materials and Methods
We used 49 two-month-old naı¨ve male Wistar rats bred
in our laboratory (mean weight 297.9 ± 27.8 g). All rats
were housed singly, kept under a 12 h light-dark cycle (lights
on at 8:00 a.m.) and in controlled temperature (20–22∘C)
and humidity (40–70%) conditions. Food and water were
provided ad libitum. All procedures were performed in
compliance with the directive for care and use of laboratory
animals of the European Community Council (86/609/EEC)
and of the Autonomous Government of Catalonia (DOGC
2073 10/7/1995).
Starting from the day after being housed, the animals
were handled for 5min on three consecutive days and were
randomly assigned to either TBI or sham injury. TBI was
produced using a CCI device (Pittsburgh Precision Instru-
ments, Inc., Pittsburgh, USA). Deep anesthesia was induced
using 5% isoflurane (Forane, Abbot Laboratories, Madrid,
Spain) in oxygen (2 L/min) in a Plexiglas chamber (20 ×
13 × 13 cm) for 7min and maintained using a nose mask
with 2% isoflurane in oxygen (1 L/min). Rats were placed
in a stereotaxic frame (David Kopf Instruments, Tujunga,
USA) and a midline scalp incision was made followed by
a craniotomy (4mm diameter) in the right hemisphere
(+0.45mm posterior to Bregma and +0.3mm lateral to the
midline). The impactor rod was angled 15∘ degrees vertically
and had an impact tip of 3mm. The parameters of the
impact were velocity of 6m/s; dwell time of 150 mms; and
2mm depth from the dura mater surface. At the end of
surgery, 0.2mL buprenorphine (Buprex, Schering-Plough,
SA,Madrid, Spain) was administered. Similar surgical proce-
dures were conducted in Sham animals, including anesthesia
and craniotomy, but without the cortical impact.
For object recognition procedures, an open box (65.5 cm
width × 65.5 cm length × 35 cm height) made of conglom-
erate covered with brown melamine, enclosed in a sound-
attenuating cage (72 cm width × 72 cm length × 157 cm
height) made from white melamine, and ventilated by an
extractor fan, was used. The illumination on the floor of the
box was 30 lux. Four different objects, not known to have
any ethological significance for the rats and completely new
for the animals, varying in shape, color, and size, were used,
three for the object recognition task (an object constructed
from Lego, a can, and a plastic hanger) and one for the
neophobia test (object constructed from Lego). They were
fixed to the floor with adhesive tape to prevent the animals
from moving them. To avoid the presence of olfactory cues,
the apparatus and objects were thoroughly cleaned with a
70% ethanol solution and dried before the first rat and after
each animal. All behavioral sessions were recorded by a video
camera mounted above the experimental apparatus. Tapes
were analyzed offline by a trained observer who was unaware
of the experimental condition of the animals or of which
object was familiar with and which was the novel one.
One week after surgery, rats received three sessions of
habituation to the experimental apparatus on two consecutive
days (two sessions on the first day, 2 h interval, one session
on the second day). To determine the emotional reactivity to
a novel object, a neophobia test was conducted 2 h after the
last habituation. The animals were placed in the box facing
away from an object located in the center of the box and were
allowed to explore it for 10min.The time exploring the object
was recorded. Throughout the experiment, exploration was
defined as directing the nose at the object at a distance of
≤2 cm or touching it with the nose. Turning around or sitting
on the objectwas not considered exploratory behavior.Object
recognition training took place the day after the neophobia
test. In the training session, two identical objects were placed
near the two corners of one side of the cage. The rats were
placed in the experimental apparatus, facing the center of
the opposite wall, and were allowed to explore for 15min.
Time spent exploring each object was recorded. An exclusion
criterion of a minimum of 10 s of total exploration in the
training trial was established.
Immediately after training, the animals received either
0.01mg/kg intraperitoneal (i.p.) epinephrine [(−)epinephrine
bitartrate, Sigma Chemical, Madrid, Spain] (Epi group),
i.p. distilled water (vehicle; Veh groups), or no injection
(0 groups). The dose of epinephrine was chosen according
to previous experiments [11]. Thus, the final experimental
groups were the following ones: Sham-0, Sham-Veh, TBI-0,
TBI-Veh, and TBI-Epi.
Retention was tested 3 h (RT1) and 24 h (RT2) after the
training trial. In both sessions, one copy of the familiar object
and a novel object were placed in the same location as that of
the objects used during the training trial. The novel object
used in RT1 was different from the one used in RT2. The
position of the objects in the tests and the objects used as
novel or familiar were counterbalanced. The rats were placed
in the open box and allowed to explore both objects for 5min,
and the time spent exploring each object was recorded. To
analyze cognitive performance, a discrimination index was
calculated [(time exploring the novel object − time exploring
the familiar object) × 100/total time spent on both objects],
which made adjusting for any differences in total exploration
time possible. As this task is based on the natural tendency of
rats to explore novelty, an index significantly higher than zero
is considered a good recall of the familiar object, whereas an
index close to zero is considered a lack of recall [20].
At the end of the experiment, the animals were killed with
an overdose of sodium pentobarbital (Dolethal, 200mg/kg;
Vetoquinol S.A., Madrid, Spain) and perfused transcardially
with 4% 0.1M phosphate-buffered paraformaldehyde (PFA),
pH 7.4. Brains were removed and stored in PFA for 3 h at
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Table 1: Mean values (SEM) of the total exploration times (s) in the neophobia, acquisition, and retention sessions for each experimental
group.
Sham-0 Sham-Veh TBI-0 TBI-Veh TBI-Epi
Neophobia 88.1 (16) 99 (21.2) 71.7 (22.7) 121.3 (18.2) 108.3 (18.5)
Acquisition 111.4 (14.5) 146.3 (19.7) 96 (21.8) 145.2 (10.6) 122 (17.4)
3 h retention 48.2 (6.9) 60 (6.8) 52 (5.4) 57 (5.4) 57.7 (9.4)
24 h retention 57.4 (8.7) 47 (4.9) 43.9 (6.8) 43.7 (4) 40.6 (4.5)
−4∘C and subsequently rinsed three times (20min delay) in
phosphate buffer at 4∘C and were kept 48 h in 30% buffered
sucrose at 4∘C for cryoprotection. The tissue was then
stored at −80∘C until being sectioned (40 𝜇m) on a cryostat
(Shandon Cryotome FSE, Thermo Electron Corporation,
Madison, USA). Throughout the extent of the brain where a
lesion cavity was visually apparent, one in ten sections was
taken for subsequent staining in cresyl violet and digitalized
with a scanner (HP Scanjet G4050). Using the image analysis
software ImageJ 1.45 s, digital images were calibrated and the
area of the lesion for each slice wasmeasured. To calculate the
volume of the lesion, the area of the lesion cavity in each slice
was multiplied by 0.04mm (slices width) and by 10 (number
of sections until the next slice analyzed).
SPSS 19.0 (Chicago, USA) was used for data analyses.
Analysis of variance (ANOVA) was applied considering
group (Sham-0, Sham-Veh, TBI-0, TBI-Veh, and TBI-Epi)
as the qualitative independent variable and total exploration
times in the neophobia, training, and retention tests as quan-
titative dependent variables. To analyze retention, repeated
measures analyses of variance were used considering group
as the independent variable and the discrimination index at
RT1 and RT2 as the dependent variables. Bonferroni post hoc
tests were conducted when necessary.
One-sample 𝑡-tests were used to determine whether the
discrimination index was different from zero (chance level).
Differences in lesion volume were analyzed with an ANOVA
considering group (TBI-0, TBI-Veh, and TBI-Epi) as the
independent variable and lesion volume as the dependent
variable. Statistical significance was set at the level of 𝑃 ≤
0.05.
One rat in the Sham-Veh group showing a total explo-
ration time < 10 s on acquisition was excluded from the
analyses. Boxplot identified six subjects (Sham-0 = 1, Sham-
Veh = 2, TBI-Veh = 1, and TBI-Epi = 2) with outlier values in
RT1 or RT2, whichwere excluded from the analyses.Thus, the
total number of rats per groupwas as follows: Sham-0 (𝑛 = 9),
Sham-Veh (𝑛 = 7), TBI-0 (𝑛 = 9), TBI-Veh (𝑛 = 10), and TBI-
Epi (𝑛 = 7).
3. Results
Figure 1 shows a coronal section of the brain in one represen-
tative TBI subject.Themean lesion volume inmm3 (±SD) for
each group was TBI-0 (5.2 ± 3), TBI-Veh (7.1 ± 4), and TBI-
Epi (5.7±3.3). No significant differences were found between
groups.
No significant differences were found among groups in
total exploration time during the neophobia, training, or
retention sessions (see Table 1).
Figure 1: Representative lesion induced by CCI.
𝑡-tests showed that the discrimination index in RT1 was
significantly different from zero (indicating a significant
recall) in Sham-0 (𝑡
8
= 8.42, 𝑃 < 0.001), Sham-Veh (𝑡
6
=
4.24, 𝑃 = 0.005), and TBI-Epi (𝑡
6
= 6.72, 𝑃 = 0.001) groups
and did not differ from 0 (indicating lack of recall) in TBI-
0 and TBI-Veh groups. In RT2, the discrimination index was
significantly different from zero in all groups except for TBI-
0 group (Sham-0: 𝑡
8
= 4.5, 𝑃 = 0.002; Sham-Veh: 𝑡
6
= 13.2,
𝑃 < 0.001; TBI-Veh: 𝑡
9
= 3.25, 𝑃 = 0.010; and TBI-Epi: 𝑡
6
=
10, 𝑃 < 0.001). Therefore, whereas TBI-0 did not remember
the familiar object on RT1 and RT2 and TBI-Veh on RT1, TBI-
Epi and Sham groups remember it on both retention sessions
(Figure 2).
Mixed analyses of variance showed that the main factor
group was significant (𝐹
4,37
= 10.56, 𝑃 < 0.001), while
neither session nor group × session interaction was significant.
Bonferroni post hoc tests showed that the discrimination
index of TBI-0 group was significantly lower than that of
Sham-0 (𝑃 = 0.001), Sham-Veh (𝑃 = 0.001), and TBI-Epi
(𝑃 < 0.001) groups, but not lower than that of TBI-Veh group.
The same analyses showed that TBI-Veh was significantly
lower than that of TBI-Epi (𝑃 = 0.01). No other differences
were detected (Figure 2).
4. Discussion
The main results from this study were as follows: (1) TBI
produced significant impairment of object recognitionmem-
ory, (2) posttraining i.p. epinephrine was able to reverse this
memory deficit, and (3) systemic administration of distilled
water also had a positive effect, but of smaller magnitude.
Our data demonstrates that TBI produces object recog-
nition memory deficits at the two times tested (3 and
24 h). Specifically, while in nonlesioned rats (Sham-0) the
discrimination index was significantly different from zero at
both delays, the discrimination index of TBI-0 group did not
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Figure 2:Mean value (+SEM) of the discrimination index at 3 h and
24 h retention tests. ∗: statistically significant differences compared
to zero; I: statistically significant differences between groups.
differ from zero in any of the retention sessions. Moreover,
performance of TBI-0 group was significantly lower than
that of Sham groups. This deficit is consistent with previous
results using object recognition memory in rodents [18, 19,
21–26] and also with other studies with different behavioral
procedures in both humans and animals, thus showing that
anterograde amnesia is a common sequel of TBI [3, 17].
The group differences in behavioral outcome were not likely
due to differences in anxiety when faced with a new object
or in exploration times during acquisition or retention ses-
sions, as no differences between groups were observed when
these variables were analyzed. Spontaneous object preference
can also be ruled out because new and old objects were
counterbalanced. However, since TBI was present before the
beginning of the behavioral procedures, it is not possible to
establish whether the observed effects are due to differences
in attending or encoding information during training or to
deficits in storage or retrieval information.
Posttraining epinephrine reversed these memory deficits.
Injured rats with posttraining epinephrine (TBI-Epi group)
spent significantly more time exploring the novel than the
familiar object in both retention sessions, showing good recall
of the task on both sessions. Moreover, their level of per-
formance was significantly higher than that of lesioned rats
(TBI-0 and TBI-Veh) and similar to that of nonlesioned rats
(Sham-0 and Sham-Veh).That is, the amount of enhancement
of posttraining epinephrine was enough to bring lesioned
rats’ memory performance to the level of nonlesioned rats.
What may have been the mechanisms mediating the
benefits of epinephrine on performance inmemory tests? It is
highly unlikely that the effects found might be attributed to a
neuroprotective action, since epinephrine was administered
only once, in a posttraining contingent basis (immediately
after the acquisition session) and 10 days after injury (and
thus, not in the acute postinjury period). In concordancewith
this, no differences in the size of the lesion cavity were found
between the different TBI groups. The fact that epinephrine
was administered after the acquisition session also rules
out the possibility that the improvement effect was due
to epinephrine-induced effects on attention, motivational,
motor, or sensory processes during training. We cannot
rule out that the effect on 3 h retention could be due to a
proactive effect on retrieval, since the fact that some effect
induced by this treatment could persist along this relatively
short delay between injection and retention cannot be dis-
regarded. Nevertheless, this possibility seems unlikely since
it has been reported that posttraining epinephrine improved
object recognition memory when tested 96 h, but not 1.5 h,
after treatment [27]. In contrast, the effect of posttraining
epinephrine is consistent with multiple data in healthy
animals indicating that this treatment enhances memory by
acting on memory consolidation mechanisms [13]. While
there is substantial evidence that epinephrine modulates
memory for highly arousing aversively motivated task, the
present results confirm previous reports in nonlesioned rats
showing that posttraining epinephrine is also able to improve
memory for tasks with a very low emotional component such
as object recognition [11, 27].
As epinephrine does not readily cross the blood-brain
barrier [28] its effects on memory consolidation appear
to be initiated on peripheral actions. There are two major
views regarding the mechanisms by which epinephrine can
modulate memory consolidation. One is based on the idea
that epinephrine activates the beta-adrenoceptors located on
vagal afferents that project to the nucleus of the solitary
tract in the brain stem that sends noradrenergic projections
to forebrain regions including the amygdala. Another view
suggests that the effects of posttraining epinephrine would
be mediated by the glucose released into the blood by the
activation of hepatic adrenoreceptors [13, 29]. While both
vagal- and glucose-mediated pathways have been explored to
decrease cognitive deficits after brain injury [30, 31], to our
knowledge this is the first time that a single and contingent
posttraining epinephrine dose has been shown to revert
memory deficit seen after a long postinjury delay (10 days).
Intraperitoneal administration of distilled water also
exerted a positive, but less powerful, effect on cognition.
Rats of the TBI-Veh group were able to remember the
familiar object, but only on the second retention session, and
showed a level of performance lower than TBI-Epi group
but intermediate between Sham rats and TBI nontreated
rats. In this sense, performance of rats of TBI-Veh group
was significantly lower than that of TBI-Epi group but did
not significantly differ from Sham-0, Sham-Veh, and TBI-0
groups. Although we do not have direct measures of that,
the present results could suggest that the injection of distilled
water induced some degree of emotional arousal that was
able to enhance memory modulation, in a similar way than
posttraining epinephrine. Since this effect of posttraining
injections on memory has not been found in nonlesioned
rats (Sham-Veh) or in previous experiments using similar
handling procedures and memory task [11], the present
results might indicate that even low levels of emotional
arousal can enhance performance inmemory tasks in animals
that present a clear memory deficit, such as after TBI, at least
at the postinjury time point used here (10 days).
Our results suggest that an acute contingent posttraining
treatment could be a potential way to alleviate memory
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deficits associated with TBI. It is important to note that
posttraining injections of epinephrine would not be the best
choice for patients due to several clinical contraindications
(e.g., sulfate sensitivity, diagnosis with closed-angle glau-
coma, and altered blood pressure) and interactions with sev-
eral drugs (e.g., tricyclic antidepressants, halogenated anes-
thetics, and beta blockers) [32]. However other therapeutic
strategies could be used in humans to induce an arousal level
similar to that produced with posttraining administration
of epinephrine. There is evidence that the induction of a
moderate degree of muscle tension, which increases arousal
and causes a physiological response similar to that obtained
with peripheral administration of posttraining epinephrine,
is also capable of positively modulating memory processes in
humans [33, 34] and even of bringing memory performance
of older adults to the level of unmodulated younger adults
[35].This kind of treatment could be easily and noninvasively
self-administered by the patient on demand, for example, by
squeezing a hand dynamometer [33, 34] or a sand-filled ball
[35].
5. Conclusions
This study shows that TBI produced significant impair-
ment of object recognition memory and that posttraining
epinephrine was able to reverse this memory deficit. Post-
training administration of vehicle had also a positive effect,
but of smaller magnitude. These results raise the possibility
that administering acute treatments contingently to a given
task and aimed at improving the specific cognitive processes
triggered by it could constitute a complementary approach
to therapeutic strategies targeted to reduce the alterations in
brain function associated with brain damage.
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